Titre:apotex - innovating for patient affordability
La description :skip to main menu | skip to main content apotex worldwide drop down menu : ww_country select country australia belgium canada czech republic india mexico netherland new zealand poland spain united sta...
Classement Alexa Global: # 312,164,Alexa Classement dans Canada est # 16,668
Server:Microsoft-IIS/8.5...
X-Powered-By:ASP.NET
L'adresse IP principale: 209.29.196.241,Votre serveur Canada,Brampton ISP:Telus Communications Inc. TLD:com Code postal:ca
Ce rapport est mis à jour en 11-Jun-2018
Created Date: | 1996-09-14 |
Changed Date: | 2016-09-13 |
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte apotex.com.Actuellement, hébergé dans Canada et son fournisseur de services est Telus Communications Inc. .
Latitude: | 43.683410644531 |
Longitude: | -79.766326904297 |
Pays: | Canada (ca) |
Ville: | Brampton |
Région: | Ontario |
ISP: | Telus Communications Inc. |
domaine | Titre |
---|---|
apotex.com | apotex - innovating for patient affordability |
ragimarchery.com | ragim: innovating archery tradition |
ragim.org | ragim: innovating archery tradition |
etp-journal.org | éducation thérapeutique du patient / therapeutic patient education (etp/tpe) |
patientsansfrontieres.fr | patient sans frontières patient sans frontières : blog sur les soins medicaux à |
polyrythmic.org | polyrythmic : innovating and competitive music softwares & plugins vst rtas au |
followpatient.com | accueil - follow patient - follow patient |
espace-patient.com | espace patient |
lepatient.ca | magazine le patient - accueil |
monipsante.com | Portail patient - IP santé |
apicea-masante.fr | wifi patient apicéa |
ccweb-patient.fr | ccweb-patient - connexion |
medical-sip.fr | sip suivi informatisé du patient |
monelivie.fr | portail patient - élivie |
satispharma.fr | satispharma - expérience patient |
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Microsoft-IIS/8.5 contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
X-AspNet-Version: | 4.0.30319 |
Content-Encoding: | gzip |
Content-Length: | 8858 |
Expires: | -1 |
Vary: | Accept-Encoding |
X-Powered-By: | ASP.NET |
Server: | Microsoft-IIS/8.5 |
Pragma: | no-cache |
Cache-Control: | no-cache |
Date: | Sun, 10 Jun 2018 20:38:26 GMT |
Content-Type: | text/html; charset=utf-8 |
soa: | ns1.apotex.net. hostmaster.apotex.com. 2017031645 1800 600 3600 3600 |
txt: | "odP4LHwRmfGh+9jyfeLkka4QgfdoDwVrAfPo8WGJVO+94aBvF3uP8DvvVdLuNahYcoIw3xmdbvyxOFOZDg6whw==" "pardot400592=98c082cd7e93484e70297a5edd60c17c7655fc1daf86b8d36fc6baf3fb136fcf" "v=spf1 include:spf.protection.outlook.com include:spf.apotex.com include:_spfblock.salesforce.com include:_spf.salesforce.com include:et._spf.pardot.com include:nets1.spf.messagelabs.com -all" |
ns: | ns1.apotex.net. dns2.tidc.telus.com. |
ipv4: | IP:209.29.196.241 ASN:852 OWNER:ASN852 - TELUS Communications Inc., CA Country:CA |
mx: | MX preference = 10, mail exchanger = apotex-com.mail.protection.outlook.com. |
skip to main menu | skip to main content apotex worldwide drop down menu : ww_country select country australia belgium canada czech republic india mexico netherland new zealand poland spain united states other countries search: search toggle navigation home about us about apotex corporate responsibility our leadership press center products healthcare professionals r & d research & development bioequivalence clinical studies business opportunities international business development opportunities co-development out-licensing in emea submit your opportunity careers contact us apotex worldwide previous next products access our product catalogue, discover our latest products, and optimise your time using our catalog services. clinical trials we recruit healthy individuals to participate as a subject in our clinical trials. remuneration is provided upon completion of the study. careers join apotex and discover the endless opportunities. we’d love to hear how you can contribute to our team. news apobiologix applauds supreme court decision in sandoz biosimilar case. apotex blog pass the creates act to end manipulative practices that cost our patients billions since apotex’s inception over 40 years ago, our company has focused on a sole purpose: improving access to affordable, innovative and high-quality medications. ... full story how can generics organizations harness their strengths to adopt agility? in a 2015 mckinsey quarterly article , the authors assert that a company’s ability to be both stable and nimble is the true essence of organizational agility. ... full story apotex remembers dr. barry sherman it is with profound sadness that we announce the unexpected passing of our founder, dr. bernard c. sherman, chairman of the board of the apotex group of companies, at the age of 75, and his wife honey sherman. ... full story more articles legal & copyright terms privacy policy global business ethics & compliance uk tax strategy public advisories follow us : about us about apotex corporate responsibility our leadership press center products healthcare professionals r & d research & development bioequivalence clinical studies business opportunities international business development opportunities co-development out-licensing in emea submit your opportunity careers contact us apotex worldwide search: search all other brand or product names located in this site are trademarks of their respective holders. © apotex inc. 2018. all rights reserved.
http://www1.apotex.com/global/global
http://www1.apotex.com/global/global/business-opportunities
http://www1.apotex.com/global/global/business-opportunities/international-business-development-opportunities
http://www1.apotex.com/global/global/business-opportunities/submit-your-opportunity
http://www1.apotex.com/global/global/careers
http://www1.apotex.com/global/global/global-business-ethics-and-compliance
http://www1.apotex.com/global/global/blog
http://www1.apotex.com/global/global/r-n-d
http://www1.apotex.com/global/#maincontent
http://www1.apotex.com/global/global/about-us/about-apotex
http://www1.apotex.com/global/blog/apotex-blog/2018/06/06/pass-the-creates-act-to-end-manipulative-practices-that-cost-our-patients-billions
http://www1.apotex.com/global/global/contact-us/apotex-worldwide
http://www1.apotex.com/global/global/healthcare-professionals
http://www1.apotex.com/global/#mainmenu
http://www1.apotex.com/global/global/public-advisories
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: APOTEX.COM
Registry Domain ID: 2040536_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2016-09-13T23:03:21Z
Creation Date: 1996-09-14T04:00:00Z
Registry Expiry Date: 2026-09-13T04:00:00Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS2.TIDC.TELUS.COM
Name Server: NS1.APOTEX.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-26T09:07:02Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Network Solutions, LLC.
SERVERS
SERVER com.whois-servers.net
ARGS domain =apotex.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME apotex.com
CHANGED 2016-09-13
CREATED 1996-09-14
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
DNS2.TIDC.TELUS.COM 209.202.110.121
NS1.APOTEX.NET 209.29.196.220
REGISTERED yes
La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.